COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Nanomedicine Award 2017

The European Technology Platform for Nanomedicine (ETPN) and the EU-funded consortium ENATRANS have launched the third edition of the Nanomedicine Award to honor the best international nanomedicine innovations for 2017.

The goal of the Award is to promote and reward two excellent innovative nanomedicine-based solutions that could bring significant benefits to patients, answering unmet medical needs.

The Award is open to companies as well as academic and private researchers across the globe. Nominated projects should be totally new diagnostic and therapeutic approaches that address unmet medical needs with nanomedicine, and have an explicit and defined potential market.

Nanomedicine proposals will be evaluated in two categories:

  • Most promising nanomedicine project
  • Best nanomedicine product or deal

For more information and to apply, please visit:

Deadline to apply is August 25, 2017